9780896036734 - Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development) (19 Ergebnisse)

hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Couverture rigide. Zustand: bon. R160225216: 2002. In-8. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. XIV + 420 pages - ouvrage en anglais - nombreuses figures en noir et blanc dans le texte - tampon sur la page de garde et sur la page de titre. . . . Classification Dewey : 420-Langue anglaise. Anglo-saxon.

Zustand: Used. pp. 440.

Zustand: Used. pp. 440 Illus.

Zustand: Used. pp. 440.

Zustand: New. In.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer. Editor(s): Jordan, V. Craig; Furr, B. J. A. Series: Cancer Drug Discovery and Development. Num Pages: 420 pages, 36 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 28. Weight in Grams: 814. . 2002. Hardback. . . . .

Hardcover. Zustand: Brand New. indexed edition. 420 pages. 9.00x6.25x1.25 inches. In Stock.

Zustand: New. This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer. Editor(s): Jordan, V. Craig; Furr, B. J. A. Series: Cancer Drug Discovery and Development. Num Pages: 420 pages, 36 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 28. Weight in Grams: 814. . 2002. Hardback. . . . . Books ship from the US and Ireland.

Zustand: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Hardcover. Zustand: Like New. Like New. book.

Gebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. An Introduction to the Regulation of Sex Steroids for the Treatment of CancerV. Craig Jordan and Barrington J. A. FurrPart I. Preclinical AntiestrogensAntiestrogens and the Cell CycleColin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilc.

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide. Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics. 440 pp. Englisch.

Buch. Zustand: Neu. Hormone Therapy in Breast and Prostate Cancer | B. J. A. Furr (u. a.) | Buch | xiv | Englisch | 2002 | Humana Press | EAN 9780896036734 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying targeted hormonal treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 440 pp. Englisch.

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide. Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics.